CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.
Saved in:
| Title: | CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial. |
|---|---|
| Authors: | Benza, Raymond L.1 (AUTHOR) chenza.consulting@gmail.com, Adamson, Philip B.2 (AUTHOR), Bhatt, Deepak L.3 (AUTHOR), Frick, Fredrik4 (AUTHOR), Olsson, Gunnar5 (AUTHOR), Bergh, Niklas5,6 (AUTHOR), Dahlöf, Björn4,5 (AUTHOR) |
| Source: | Pulmonary Circulation. Jan2024, Vol. 14 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20458932 |
|---|---|
| DOI: | 10.1002/pul2.12323 |
